Key takeaways
Levemir (insulin detemir) and Ozempic (semaglutide) are both medications used to manage diabetes, but they belong to different medication classes and have distinct uses. Levemir is a long-acting insulin used for both Type 1 and Type 2 diabetes, while Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist specifically approved for Type 2 diabetes. Levemir is injected once or twice daily, whereas Ozempic is injected once a week. Levemir is available in vials and pens, while Ozempic is available as a prefilled pen. Neither medication has a generic available. Common side effects of Levemir include low blood sugar and headaches, while Ozempic can cause nausea, vomiting, and diarrhea. Both Levemir and Ozempic can be used with other diabetes medications, but this can also increase the risk of low blood sugar. Additionally, Ozempic is not recommended for people with a history of certain thyroid cancers, while Levemir does not have this warning.
